CYP24A1 and stage 5 chronic kidney disease: In a recent long-term follow-up of 18 patients with CYP24A1 and SLC34A1 mutations, impaired kidney function at a mean age of 23.8 years was found in 77%, including two adults with end-stage renal disease.